Why MENA pharma investment is a risk-reward play

In the MENA region, nascent manufacturing capabilities are laying attractive foundations for pharma investment. But, as Elena Ghose, Pharmaceuticals & Healthcare Analyst at Fitch Solutions explains, regulatory and pricing hurdles must be addressed